Airbus Expects Higher Plane Deliveries For 2023, But Cautious On Production For A320
Today, 9:36 AM
Airbus SE’s (OTC:EADSY) (OTC:EADSF) FY22 revenues increased 13% Y/Y to €58.8 billion. Revenues generated by Airbus’ commercial aircraft activities increased by…
Labcorp FY23 Adj. EPS Outlook $16.00 – $18.00 Vs. $17.71 Estimate, Free Cash Flow $1.0B – $1.2B
Today, 9:36 AM
2023 Guidance
The following guidance assumes foreign exchange rates effective as of Dec. 31, 2022, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital
Visteon FY23 Outlook: Revenue $3.95B – $4.15B Vs. $3.93B Estimate, EBITDA $405 – $445M, FCF $115M – $165M
Today, 9:36 AM
Robust Growth in 2022 and Strong Outlook for 2023
"The Visteon team had a strong finish to round out a successful 2022, again achieving market out-performance along with 45 new program launches and $6 billion in
Henry Schein Expects FY23 Adjusted EPS of $5.25-$5.42 Vs. 4.95 Estimate
Today, 9:36 AM
2023 sales growth is expected to be approximately 1% to 3% over 2022.
2023 sales of PPE products and COVID-19 test kits are expected to decrease in aggregate by
US Foods, Applied Materials And 3 Stocks To Watch Heading Into Thursday
Today, 9:36 AM
With US futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Telefônica Brasil S.A. 4Q22 Results R$12.659B Vs R$11.501B YoY; Company Also Approved The New Share Buyback Program Of Up To R$500M In Ordinary Shares And The Cancellation Of Treasury Shares; Sees FY23 CAPEX Will Reach Up To R$9B
Today, 9:36 AM
ALL CURENCY METRICS ARE IN BRAZIL REAIS (R$)
SÃO PAULO, Feb. 15, 2023 /PRNewswire/ -- Telefônica Brasil - ((B3: VIVT3, NYSE:VIV), announces its results for 4Q22 and 2022.
Vivo reinforces
Canada’s Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Today, 9:36 AM
Ontario-based Red Light Holland Corp. (OTCQB: TRUFF) has committed to becoming an aligned supporter and advocate with the non-profit TheraPsil.
Ryder System Beats On Q4; Forecasts Reduced 2023 Earnings On Slowing Macroeconomic & Freight Environment
Today, 9:36 AM
Ryder System Inc (NYSE:R) reported fourth-quarter FY22 sales growth of 19% year-on-year to $3.09 billion, beating the consensus of $3.04 billion.…
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
Today, 9:36 AM
Israeli-based next-gen psychedelics biotech Clearmind Medicine (NASDAQ: CMND) together with partner clinical-stage pharma company SciSparc (NASDAQ: SPRC) has filed three provisional patent applications with the United S